Trial Profile
Phase I trial of GVAX melanoma vaccine.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 22 Jul 2011
Price :
$35
*
At a glance
- Drugs Tumour cell vaccine-GVAX (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 22 Jul 2011 New trial record